At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Posted on: 15 November, 2024
We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, ..... Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Presentations, Research Excellence
Posted on: 12 November, 2024
Our Kolling Institute newsletter brings together a collection of profiles on our impressive research..... Read more
Category: New Treatment, Newsletters, Research Excellence
Posted on: 23 October, 2024
Kolling Institute researcher and Royal North Shore Hospital endocrinologist Professor Rory Clifton-B..... Read more
Category: New Treatment, Research Excellence